| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.16B | 39.26B | 34.87B | 33.56B | 29.16B | 32.42B |
| Gross Profit | 8.17B | 8.17B | 6.12B | 5.38B | 4.80B | 5.81B |
| EBITDA | 3.37B | 4.00B | 1.53B | 1.05B | 651.00M | 1.42B |
| Net Income | 2.73B | 2.74B | 899.00M | 556.00M | 310.00M | 885.00M |
Balance Sheet | ||||||
| Total Assets | 30.47B | 33.38B | 32.42B | 31.58B | 28.46B | 29.23B |
| Cash, Cash Equivalents and Short-Term Investments | 660.00M | 892.00M | 1.45B | 1.60B | 1.59B | 1.54B |
| Total Debt | 531.00M | 514.00M | 572.00M | 589.00M | 608.00M | 738.00M |
| Total Liabilities | 8.95B | 11.46B | 11.97B | 12.86B | 9.92B | 10.57B |
| Stockholders Equity | 21.39B | 21.81B | 20.35B | 18.63B | 18.46B | 18.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.01B | 135.00M | 71.00M | -977.00M | 2.62B |
| Operating Cash Flow | 0.00 | 1.12B | 190.00M | 123.00M | -589.00M | 2.85B |
| Investing Cash Flow | 0.00 | -249.00M | 13.00M | 238.00M | 986.00M | -2.96B |
| Financing Cash Flow | 0.00 | -1.08B | -418.00M | -411.00M | -534.00M | -417.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥282.69B | 16.21 | 9.20% | 2.78% | 1.31% | 59.20% | |
76 Outperform | ¥101.86B | 18.89 | ― | 4.38% | -0.84% | -1.80% | |
76 Outperform | ¥61.83B | 21.61 | ― | 2.01% | 14.48% | 122.79% | |
74 Outperform | ¥345.45B | 19.95 | 12.41% | 1.68% | 8.09% | 20.78% | |
74 Outperform | ¥748.49B | 22.29 | ― | 2.15% | -5.20% | -1.20% | |
72 Outperform | ¥1.43T | 25.17 | 14.15% | 2.00% | 16.43% | 53.76% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |